A 52-year-old male with diabetic foot ulcer develops cellulitis with purulent drainage. Wound culture grows oxidase-positive Gram-negative rods. The patient is afebrile and haemodynamically stable. Local antibiotic sensitivities show resistance to fluoroquinolones and aminoglycosides but sensitivity to piperacillin-tazobactam and carbapenems. What is the most appropriate next step in management?

Explanation

## Clinical Context **Key Point:** The patient has *Pseudomonas aeruginosa* soft-tissue infection (diabetic foot ulcer with cellulitis). The organism is resistant to fluoroquinolones and aminoglycosides but susceptible to piperacillin-tazobactam and carbapenems. The patient is haemodynamically stable and afebrile — this is NOT an emergency requiring immediate surgical intervention or carbapenem escalation. ## Management Algorithm for *P. aeruginosa* Soft-Tissue Infection ```mermaid flowchart TD A["P. aeruginosa soft-tissue infection<br/>Diabetic foot ulcer"]:::outcome --> B{Haemodynamically<br/>stable?}:::decision B -->|Yes| C{Susceptibilities<br/>available?}:::decision B -->|No| D["ICU admission<br/>Broad-spectrum IV therapy<br/>Surgical consultation"]:::urgent C -->|Yes| E{Susceptible to<br/>piperacillin-tazobactam?}:::decision C -->|No| F["Empiric broad-spectrum<br/>Carbapenem ± aminoglycoside"]:::action E -->|Yes| G["IV piperacillin-tazobactam<br/>4.5 g 6-hourly<br/>Wound care & dressing"]:::action E -->|No| H["Carbapenem<br/>Meropenem or imipenem"]:::action G --> I["Monitor clinical response<br/>Reassess at 48-72 hrs"]:::action H --> I I --> J{Improvement?}:::decision J -->|Yes| K["Continue therapy<br/>Surgical debridement if needed"]:::action J -->|No| L["Escalate: Imaging<br/>Surgical consultation"]:::action ``` ## Rationale for Piperacillin-Tazobactam | Aspect | Reasoning | |--------|----------| | **Spectrum** | Covers *P. aeruginosa* with excellent soft-tissue penetration | | **Susceptibility** | Organism is susceptible; no need to escalate to carbapenem | | **Clinical stability** | Afebrile, haemodynamically stable — no indication for ICU-level therapy | | **Cost-effectiveness** | Piperacillin-tazobactam is less expensive than carbapenem and equally effective for susceptible strains | | **Wound care** | Daily dressing changes and local wound management are essential adjuncts | **High-Yield:** In stable patients with susceptible *P. aeruginosa*, piperacillin-tazobactam is first-line. Carbapenems are reserved for resistant strains or critically ill patients. **Clinical Pearl:** Diabetic foot ulcers with *P. aeruginosa* require aggressive local wound care, off-loading, and vascular assessment in addition to antibiotics. Surgical debridement is indicated only if there is evidence of necrotizing infection or failure to improve on antibiotics — not routinely upfront in stable cellulitis. **Warning:** Do NOT use fluoroquinolones despite their oral bioavailability — the organism is resistant. Hyperbaric oxygen is an adjunctive therapy for refractory osteomyelitis or necrotizing fasciitis, not routine soft-tissue infection management. [cite:Harrison 21e Ch 157] [cite:Park 26e Ch 10]